Diagnovus and Cincinnati Children’s Hospital Partner to Develop Genetic Test for Eosinophilic Esophagitis
Molecular diagnostics company Diagnovus and Cincinnati Children’s Hospital Medical Center are partnering to commercialize the first genomic assay to help physicians diagnose and treat eosinophilic esophagitis, a debilitating inflammatory condition.
Read More